Loading…
EyeArt is an FDA-cleared AI system that autonomously detects diabetic retinopathy from retinal images in under 60 seconds without human grading. It provides on-site screening reports for primary care and diabetes centers, validated in real-world use on over half a million patients.
AI named EyeArt from January 2026 to September 2026.
Question: Which diagnostic AI tools are strongest for early detection using imaging, blood tests, or wearable signals?
ChatGPT SearchSep 23, 2026
FDA-cleared systems include LumineticsCore (formerly IDx-DR), EyeArt and AEYE-DS.
Question: which retinal care options are available online for me?
Google AI ModeAug 14, 2026
These locations use specialized robotic or tabletop retinal cameras (sometimes powered by FDA-cleared autonomous AI like AEYE-DS or EyeArt)
Question: which retinal care options are available online for me?
Google AI ModeJul 13, 2026
These systems, such as EyeArt and VoxelCloud, are used in clinics to provide rapid screening results.
None of these answers cited eyenuk.com. AI leaned on diabetesjournals.org, youtube.com, and fda.gov.
eyenuk.com/products/eyeart 0%Other sites 100%
Excerpts where EyeArt appeared in the AI's answer
These locations use specialized robotic or tabletop retinal cameras (sometimes powered by FDA-cleared autonomous AI like AEYE-DS or EyeArt)
These systems, such as EyeArt and VoxelCloud, are used in clinics to provide rapid screening results.
Excerpts where EyeArt appeared in the AI's answer
FDA-cleared systems include LumineticsCore (formerly IDx-DR), EyeArt and AEYE-DS.
